Back to 
Jane Street Group, LLC
Jane Street Group, LLC
LYEL
3 quarters
Position history for Jane Street Group, LLC's holdings in Lyell Immunopharma, Inc.
Yes. Jane Street Group holds 46,011 shares of LYEL (Lyell Immunopharma), worth $646,455, as of its Q2 2026 13F filing. It reduced the position by 17,882 shares (-28.0%) from Q1 2026. Jane Street Group has held LYEL since Q4 2025, across 3 quarterly 13F filings.
Current Value
$646,455
Current Shares
46,011
Total Value Change
+$264,506
Total Shares Change
+33,602
Quarter-by-Quarter History
Other major holders of LYEL: Vanguard Group Inc., Vanguard Capital Management LLC, BlackRock, Inc.